Delivery Order SPE2DB22D1017-SPE2DB25FE8BV

Award Date 10/29/24
Potential Completion Date 10/30/24
Potential Value $6.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Abiraterone Acetate 250 MG tablets in quantities of 120. The $1,353.08 Firm Fixed Price contract is a Delivery Order placed by the Defense Logistics Agency (DLA), a defense agency. The contract has a period of performance through June 10, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This federal contract award, with ID SPE2DB22D3019|SPE2DB25FK3EU, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,001.30 firm-fixed-price delivery order is for the supply of 4567441444 ! ABIRATERONE ACETATE 500 MG TAB 60S, a pharmaceutical product. The contract has an ultimate completion date of March 4, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Abiraterone Acetate 500 mg tablets. The contract is a firm fixed-price delivery order with a ceiling value of $1,334.05 and a period of performance through June 26, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,804.99 firm-fixed-price delivery order is for 4,567,025,743 units of Abiraterone Acetate 500 mg tablets. The contract has an ultimate completion date of January 24, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of abiraterone acetate 250 mg tablets. The contract has a ceiling value of $1,610.20 and a completion date of February 26, 2025. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,313.32, is for the supply of 4,566,561,596 units of abiraterone acetate 250 mg tablets. The contract is a firm fixed-price delivery order with a completion date of November 29, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,829,371 units of Abiraterone Acetate 500 mg tablets in 60-count packages. The contract has a ceiling value of $3,568.49 and is a firm fixed-price delivery order. Amerisourcebergen has an existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,420.28, is for the delivery of abiraterone acetate 250 mg tablets. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The contract has an ultimate completion date of March 17, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,822.78 firm fixed price delivery order is for the supply of 4565133468 Abiraterone Acetate 250 mg tablets. The contract has a ceiling value of $1,822.78 and a completion date of July 15, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award is for the delivery of 60 tablets of the medication Abiraterone Acetate 500 mg. The contract, valued at $5,394.87, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a Firm Fixed Price Delivery Order with a completion date of June 18, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FE8BV
    Delivery Order

This federal contract award, valued at $6,225.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for 4566263297 - ABIRATERONE ACETATE 500 MG TAB 60S, with a completion date of October 30, 2024. The contract has a Firm Fixed Price pricing type and does not have a set-aside designation.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/20/25, 1:58 PM